AVIR
Price
$3.10
Change
-$0.02 (-0.64%)
Updated
Jan 23 closing price
Capitalization
261.84M
39 days until earnings call
FHTX
Price
$4.38
Change
+$0.01 (+0.23%)
Updated
Jan 23 closing price
Capitalization
243.5M
41 days until earnings call
Ad is loading...

AVIR vs FHTX

Header iconAVIR vs FHTX Comparison
Open Charts AVIR vs FHTXBanner chart's image
Atea Pharmaceuticals
Price$3.10
Change-$0.02 (-0.64%)
Volume$482.52K
Capitalization261.84M
Foghorn Therapeutics
Price$4.38
Change+$0.01 (+0.23%)
Volume$61.83K
Capitalization243.5M
AVIR vs FHTX Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. FHTX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a StrongBuy and FHTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (AVIR: $3.10 vs. FHTX: $4.38)
Brand notoriety: AVIR and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 109% vs. FHTX: 39%
Market capitalization -- AVIR: $261.84M vs. FHTX: $243.5M
AVIR [@Biotechnology] is valued at $261.84M. FHTX’s [@Biotechnology] market capitalization is $243.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $360.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 3 TA indicator(s) are bullish while FHTX’s TA Score has 3 bullish TA indicator(s).

  • AVIR’s TA Score: 3 bullish, 3 bearish.
  • FHTX’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а -6.91% price change this week, while FHTX (@Biotechnology) price change was +4.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.00%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was -0.35%.

Reported Earning Dates

AVIR is expected to report earnings on May 07, 2025.

FHTX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+5.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVIR($262M) has a higher market cap than FHTX($243M). FHTX (-7.203) and AVIR (-7.463) have similar YTD gains . FHTX has higher annual earnings (EBITDA): -98.53M vs. AVIR (-200.08M). AVIR has more cash in the bank: 483M vs. FHTX (267M). AVIR has less debt than FHTX: AVIR (1.84M) vs FHTX (39.1M). FHTX has higher revenues than AVIR: FHTX (25.5M) vs AVIR (0).
AVIRFHTXAVIR / FHTX
Capitalization262M243M108%
EBITDA-200.08M-98.53M203%
Gain YTD-7.463-7.203104%
P/E RatioN/AN/A-
Revenue025.5M-
Total Cash483M267M181%
Total Debt1.84M39.1M5%
FUNDAMENTALS RATINGS
AVIR: Fundamental Ratings
AVIR
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVIRFHTX
RSI
ODDS (%)
Bearish Trend 17 days ago
82%
Bullish Trend 17 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 17 days ago
90%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 17 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 17 days ago
84%
Bearish Trend 17 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 17 days ago
75%
Bearish Trend 17 days ago
89%
Advances
ODDS (%)
Bullish Trend 22 days ago
77%
Bullish Trend 30 days ago
86%
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
Bearish Trend 26 days ago
86%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 17 days ago
90%
View a ticker or compare two or three
Ad is loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFIFX18.930.05
+0.26%
JHancock Financial Industries I
ALGAX19.27N/A
N/A
Alger International Opportunities A
CMVIX26.30N/A
N/A
BlackRock Advantage Large Cap Gr Instl
MRJIX10.07N/A
N/A
Morgan Stanley Multi-Asset Real Return I
FIKVX13.69N/A
N/A
Fidelity Advisor Asset Manager 20% Z

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with HEPA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then HEPA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-0.64%
HEPA - AVIR
47%
Loosely correlated
+48.15%
AXON - AVIR
46%
Loosely correlated
+0.95%
RCKT - AVIR
45%
Loosely correlated
+5.73%
MGTX - AVIR
45%
Loosely correlated
+0.50%
CDXS - AVIR
45%
Loosely correlated
+2.26%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with CCCC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+0.23%
CCCC - FHTX
44%
Loosely correlated
+0.81%
NTLA - FHTX
44%
Loosely correlated
+2.54%
CRSP - FHTX
43%
Loosely correlated
+0.07%
ABOS - FHTX
43%
Loosely correlated
-1.14%
AVIR - FHTX
42%
Loosely correlated
-0.64%
More